Cargando…
Results of an Intervention in an Academic Internal Medicine Clinic to Continue, Step-Down, or Discontinue Proton Pump Inhibitor Therapy Related to a Tennessee Medicaid Formulary Change
BACKGROUND: In July 2005, the State of Tennessee Medicaid Program (TennCare) announced formulary changes for proton pump inhibitors (PPIs) to be implemented in August 2005. Prior to these changes, pantoprazole was the only preferred PPI, and there were no restrictions to its use. The revised formula...
Autores principales: | Ramser, Kristie L., Sprabery, Laura R., Hamann, Gale L., George, Christa M., Will, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437514/ https://www.ncbi.nlm.nih.gov/pubmed/19422274 http://dx.doi.org/10.18553/jmcp.2009.15.4.344 |
Ejemplares similares
-
Proton-Pump Inhibitor Utilization Associated With the Change to Nonpreferred Formulary Status for Esomeprazole in the TRICARE Formulary
por: Linton, Andrea, et al.
Publicado: (2009) -
Trends in Tennessee Medicaid Acute Care: Use and Expenditures, 1974-1978
por: Cromwell, Jerry L., et al.
Publicado: (1982) -
Prescription digital therapeutics: Applying Medicaid experience to value assessment and formulary management
por: Salsabili, Mahsa, et al.
Publicado: (2023) -
The Effect of Florida Medicaid’s State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan
por: Munshi, Kiraat D., et al.
Publicado: (2018) -
Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021)